The FDA has accepted the New Drug Application for doravirine/islatravir for adults with virologically-suppressed HIV-1 infection.

The U.S. Food and Drug Administration's reviewers on Wednesday raised efficacy concerns over the use of Otsuka Pharma's drug in combination with Viatris' Zoloft for the treatment of adults with PTSD.

SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...

The SpaceX program is still in the early stages of development and the plans could change. The effort is highly reliant on ...

The uncertainty around tariffs and trade production measures has muted economic growth. President Trump has once again ...

US FDA approves Bayer’s finerenone for new indication in patients with heart failure with left ventricular ejection fraction of ≥ 40%: Berlin Wednesday, July 16, 2025, 13:00 H ...

Traditional medicine is a centuries-old practice and belief system across cultures that typically takes a holistic approach ...

New Jersey regulators have announced that they’ve awarded the state’s first four marijuana consumption lounge endorsements in ...

Experts discuss how academic publishing must change to support open science, transparency and global accessibility in a ...

The Nasdaq Composite posted its latest record finish on Tuesday, supported by a jump in shares of heavyweight Nvidia, but the ...

The field of metal oxide cluster science is rapidly evolving, offering innovative solutions and insights at the intersection ...

Another national settlement with opioid manufacturers is poised to infuse Granite State drug prevention, treatment and ...